Eltrombopag for the Treatment of Immune Thrombocytopenia: The Aegean Region of Turkey Experience

INTRODUCTION: OBJECTIVE: Immune thrombocytopenia (ITP) is an immune mediated disease characterized by transient or persistent decrease of the platelet count to less than 100 × 109/l. Although it is included in a benign disease group, bleeding complications may be mortal. With a better understanding...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	Füsun Özdemirkıran, Bahriye Payzın, H. Demet Kiper, Sibel Kabukçu, Gülsüm Akgün Çağlıyan, Selda Kahraman, Ömür Gökmen Sevindik, Cengiz Ceylan, Gürhan Kadıköylü, Fahri Şahin, Ali Keskin, Öykü Arslan, Mehmet Ali Özcan, Gülnur Görgün, Zahit Bolaman, Filiz Büyükkeçeci, Oktay Bilgir, İnci Alacacıoğlu, Filiz Vural, Murat Tombuloğlu, Zafer Gökgöz, Güray Saydam
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	Turkish Society of Hematology 2015-11-01
Σειρά:	Turkish Journal of Hematology
Θέματα:	immune thrombocytopenia thrombopoietin receptor agonist bleeding eltrombopag
Διαθέσιμο Online:	https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tjh&un=TJH-33407
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!